As of 2025-06-23, the EV/EBITDA ratio of Repligen Corp (RGEN) is -138.83. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RGEN's latest enterprise value is 6,509.37 mil USD. RGEN's TTM EBITDA according to its financial statements is -46.89 mil USD. Dividing these 2 quantities gives us the above RGEN EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 16.8x | 14.4x |
| Forward P/E multiples | 19.1x - 22.6x | 20.1x |
| Fair Price | (7.72) - 14.95 | 2.29 |
| Upside | -106.5% - -87.4% | -98.1% |
| Date | EV/EBITDA |
| 2025-06-18 | -137.26 |
| 2025-06-17 | -141.42 |
| 2025-06-16 | -147.51 |
| 2025-06-13 | -149.22 |
| 2025-06-12 | -153.75 |
| 2025-06-11 | -154.59 |
| 2025-06-10 | -155.63 |
| 2025-06-09 | -154.21 |
| 2025-06-06 | -150.16 |
| 2025-06-05 | -148.24 |
| 2025-06-04 | -148.06 |
| 2025-06-03 | -145.48 |
| 2025-06-02 | -138.50 |
| 2025-05-30 | -137.90 |
| 2025-05-29 | -142.99 |
| 2025-05-28 | -141.63 |
| 2025-05-27 | -143.26 |
| 2025-05-23 | -138.00 |
| 2025-05-22 | -140.75 |
| 2025-05-21 | -140.46 |
| 2025-05-20 | -149.31 |
| 2025-05-19 | -147.63 |
| 2025-05-16 | -148.00 |
| 2025-05-15 | -144.12 |
| 2025-05-14 | -149.85 |
| 2025-05-13 | -154.05 |
| 2025-05-12 | -156.65 |
| 2025-05-09 | -144.09 |
| 2025-05-08 | -149.62 |
| 2025-05-07 | -148.46 |
| 2025-05-06 | -152.67 |
| 2025-05-05 | -165.28 |
| 2025-05-02 | -165.99 |
| 2025-05-01 | -160.82 |
| 2025-04-30 | -161.77 |
| 2025-04-29 | -163.49 |
| 2025-04-28 | -168.53 |
| 2025-04-25 | -169.87 |
| 2025-04-24 | -170.44 |
| 2025-04-23 | -165.85 |
| 2025-04-22 | -162.89 |
| 2025-04-21 | -154.16 |
| 2025-04-17 | -152.19 |
| 2025-04-16 | -154.71 |
| 2025-04-15 | -148.14 |
| 2025-04-14 | -148.91 |
| 2025-04-11 | -143.64 |
| 2025-04-10 | -134.45 |
| 2025-04-09 | -144.83 |
| 2025-04-08 | -126.90 |